Cargando…

Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project

Dyslipidaemia plays a major role in the pathogenesis of atherosclerosis. Every year, scientific institutions publish cardiovascular prevention guidelines with updated goals and recommendations based on new evidence. However, medical barriers exist that make achieving these goals difficult and gaps b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santi, Ricardo Lopez, Martinez, Felipe, Baranchuk, Adrian, Liprandi, Alvaro Sosa, Piskorz, Daniel, Lorenzatti, Alberto, Santi, Maria Pilar Lopez, Kaski, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2021
Materias:	Dyslipidaemia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117136/ https://www.ncbi.nlm.nih.gov/pubmed/33995586 http://dx.doi.org/10.15420/ecr.2020.42

Ejemplares similares

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: German, Charles Amir, et al.
Publicado: (2020)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: The Big Step Forward in Lipid Control
por: Rikhi, Rishi, et al.
Publicado: (2023)

El control de la hipertensión arterial, una asignatura pendiente
por: Sosa Liprandi, Álvaro, et al.
Publicado: (2022)

The new General Surgical Curriculum and ISCP
por: Lund, Jon
Publicado: (2020)

Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design
por: Burgos, Lucrecia M., et al.
Publicado: (2020)

Ending support for medical organisations puts the world at risk
por: Baranchuk, Adrian, et al.
Publicado: (2020)

Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study
por: Santi, Ricardo Lopez, et al.
Publicado: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Lorenzatti, Alberto J, et al.
Publicado: (2020)

Considerations and Guidance for the Structure, Organisation, and Operation of Cardiometabolic Prevention Units: A Consensus Statement of the Inter-American Society of Cardiology
por: Ponte-Negretti, Carlos I., et al.
Publicado: (2021)

Attitudes and Recommendations of Physicians towards Alcohol Consumption and Cardiovascular Health: A Perspective from Argentina
por: Lopez Santi, Ricardo, et al.
Publicado: (2018)

Leishmaniasis and Heart
por: Farina, Juan Ma, et al.
Publicado: (2022)

Roadblocks in Chagas disease care in endemic and nonendemic countries: Argentina, Colombia, Spain, and the United States. The NET-Heart project
por: Miranda-Arboleda, Andrés F., et al.
Publicado: (2021)

Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation
por: Liprandi, Álvaro Sosa, et al.
Publicado: (2021)

Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of Healthcare Workers in Latin America †
por: Delgado, Diego, et al.
Publicado: (2020)

Aggression, Micro-aggression, and Abuse Against Health Care Providers During the COVID-19 Pandemic. A Latin American Survey
por: García-Zamora, Sebastián, et al.
Publicado: (2022)

Impact of the Pandemic on NonInfected Cardiometabolic Patients: A Survey in Countries of Latin America—Rationale and Design of the CorCOVID LATAM Study
por: Lopez Santi, Ricardo, et al.
Publicado: (2020)

Selected Abstracts presented at the 18th International Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP), Rome, Italy, 28--30 June 2013
Publicado: (2013)

A recent experience on the role of influenza vaccination on cardiovascular events
por: Sosa-Liprandi, María Inés, et al.
Publicado: (2023)

Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021)

Psychological Impact of the Pandemic on Ambulatory Cardiometabolic Patients Without Evidence of SARS-CoV-2 Infection. The CorCOVID Latam Psy Study
por: Piskorz, Daniel, et al.
Publicado: (2021)

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial
por: Lorenzatti, Alberto J., et al.
Publicado: (2019)

Aggression, mini-aggression, and abuse against health care workers during the COVID-19 pandemic
por: Garcia-Zamora, S, et al.
Publicado: (2022)

The year in dyslipidaemia 2008 /
Publicado: (2009)

The year in dyslipidaemia 2007
Publicado: (2008)

Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)

Chagas Disease and Heart Failure: An Expanding Issue Worldwide
por: Martinez, Felipe, et al.
Publicado: (2019)

Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance
por: Paublini, Hernán, et al.
Publicado: (2023)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
por: Iyengar, S. S., et al.
Publicado: (2020)

Direct economic impact of Chagas disease treatment
por: Zaidel, Ezequiel J., et al.
Publicado: (2022)

Influenza and Pneumococcal Vaccination in Non-Infected Cardiometabolic Patients from the Americas during the COVID-19 Pandemic. A Sub-Analysis of the CorCOVID-LATAM Study
por: Sosa Liprandi, Álvaro, et al.
Publicado: (2021)

The year in dyslipidaemia : version en español 2009-2010 /
Publicado: (2010)

Dyslipidaemia in Rheumatological Autoimmune Diseases
por: Toms, Tracey E, et al.
Publicado: (2011)

The year in dyslipidaemia 2005-2006
Publicado: (2006)

Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019)

Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022)

Fixed Combination for the Treatment of Dyslipidaemia
por: Ferri, Nicola, et al.
Publicado: (2023)

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial
por: Chen, Yundai, et al.
Publicado: (2019)

Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)
por: Raal, Frederick J, et al.
Publicado: (2013)

Antiretroviral Therapy and Dyslipidaemia: Unlocking the Code
por: Mallon, Patrick W. G
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_1ulfhp6atfttpninrc93i3o0ls